Clinical Trials | November 29, 2021
AMPATH launches its pathology laboratory in Mumbai
The company has has 10 existing labs in India
The company has has 10 existing labs in India
It’s a two-dose vaccine administered 28 days apart
The campaign aims to increase awareness about Tuberculosis as a curable disease and promote early diagnosis.
The aim is to create an awareness programme that will drive diabetic patients to get their eyes tested regularly
Market demand for significant volumes and quality of biopharma products would drive continuous manufacturing technologies
This agreement marks a milestone for Baidu to use its strengths in computational biology to optimize mRNA vaccine and therapy designs
Fyarro is the first and only approved therapy for adults for the treatment of malignant PEComa in adults
The main objective of successive rounds of the NFHS is to provide reliable and comparable data relating to health and family welfare and other emerging issues
The partnership will help advance GreenLight's messenger RNA Covid-19 vaccine candidate
One-shot Sputnik Light is a highly effective vaccine when used both on standalone basis and applied as a booster
Subscribe To Our Newsletter & Stay Updated
